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Abstract
Objective: To determine anti-Candida albicans activity, cytotoxicity and drug interaction of essential oils and extracts from plants collected in 
Colombia. 
Materials and methods: The antifungal activity was evaluated following the AFST-EUCAST protocol. With most active samples, the inhibition of the 
formation of germ tubes and budding, the in vitro pharmacodynamics, using time-kill assays, and the interaction with itraconazole and amphotericin 
B following the chequerboard technique were evaluated. The cytotoxicity assay for all samples was done using MTT. 
Results: Strong activity in 17.57% of the samples was found. The lowest MIC values were obtained with Piper bredemeyeri Jacq and Lippia origanoi-
des Kunth (B) oils and Morinda royoc L extract. The three samples inhibited the formation of germ tubes and budding. P. bredemeyeri Jacq oil and M. 
royoc L extract samples showed fungicidal activity at 2xMIC. A synergistic effect was obtained with the combination of P. bredemeyeri Jacq oil and 
itraconazole, but not for the combination with amphotericin B. Active samples against C. albicans were not cytotoxic on Vero cells ATCC CCL-81, 
excluding P. bredemeyeri Jacq oil.
Conclusions: The results of this study suggest that Colombian medicinal and aromatic plants represent an untapped source of compounds with 
anti-C. albicans activity that could be a resource in the development of new therapeutic natural products.
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Resumen
Objetivo. Determinar la actividad anti-Candida albicans, la citotoxicidad y la interacción con antifúngicos de aceites y extractos de plantas recolec-
tadas en Colombia.
Materiales y métodos. La actividad antifúngica fue evaluada siguiendo el protocolo Antifungal Susceptibility Testing Subcommittee of the European 
Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Con las muestras más activas se evaluó la inhibición de la formación de tubo 
germinal y la gemación, la farmacodinamia mediante curvas de tiempo muerte y la interacción con itraconazol y anfotericina B. Se determinó la 
citotoxicidad mediante la técnica MTT.
Resultados. Se encontró actividad en 17,57 % de las muestras. La mayor actividad se obtuvo con los aceites de Piper bredemeyeri Jacq y Lippia origanoides 
Kunth (B) y el extracto de Morinda royoc L. Las tres muestras inhibieron la formación de tubo germinal y la gemación. El aceite de P. bredemeyeri Jacq y el 
extracto de M. royoc L mostraron actividad fungicida con dos veces la concentración inhibitoria mínima. Se encontró un efecto sinérgico por la combinación 
del aceite de P. bredemeyeri Jacq e itraconazol, pero no con anfotericina B. Las muestras activas no fueron citotóxicas, excepto el aceite de P. bredemeyeri Jacq.
Conclusión. Los resultados de este estudio sugieren que las plantas de Colombia son una fuente no explorada de compuestos con actividad anti-C. 
albicans, útiles para el desarrollo de nuevos productos terapéuticos. 
Palabras clave: aceites esenciales, extractos, Candida albicans, actividad antifúngica, citotoxicidad, sinergismo.
Introduction
Many researchers, particularly the ones from 
countries with a rich biodiversity, have contri-
buted to the detection of new antifungal com-
pounds in medicinal plants. Screening by using 
in vitro evaluation is a useful tool for the disco-
very of new potential antifungal agents from na-
tural products such as essential oils and extracts 
derived from plants (1). Colombia is the second ri-
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chest country in the world in biodiversity, and its 
ÁRUDOGLYHUVLW\LVHVWLPDWHGDWVSHFLHVRI
vascular plants (2). Although Colombia possesses 
a rich tradition in the use of medicinal plants, the 
antifungal activity of medicinal plants’ derivates 
has not been deeply studied. 
Candidiasis is a common infection of the skin, 
nails, oral cavity, esophagus, and vagina, caused 
by yeast of the Candida genus. Systemic yeast 
infections are a common consequence of immu-
nosuppression, long-term indwelling catheters, 
and endocrinopathies. Candida albicans is the 
most common pathogen causing that fungal 
opportunistic infection. Additionally, it has the 
ability to adhere to host surfaces or to prosthesis 
OHDGLQJWR WKH IRUPDWLRQRIELRÀOPVZKLFK IXU-
ther facilitate adhesion, infection and resistance 
to the antifungals (3).
In Colombia, different studies have shown the 
importance of C. albicans as the principal agent 
causing bloodstream fungal infection (44.7%) in 
tertiary care level hospitals (4), and as cause of 
invasive infection (43.6% and 54.5%) (5,6). 
The number of clinical infections worldwide by 
C. albicans has risen considerably in recent years, 
and the incidence of resistance to traditional an-
tifungal therapies is also increasing (7). In addition, 
GUXJUHODWHGWR[LFLW\VLJQLÀFDQWGUXJLQWHUDFWLRQV
DQGLQVXIÀFLHQWELRDYDLODELOLW\RIWKHFRQYHQWLRQDO
antifungals, have encouraged the search for new 
alternatives among natural products (8).
 
The aim of this study was to evaluate anti-C. al-
bicans activity and cytotoxicity of essential oils 
and plant extracts obtained from aromatic and 
medicinal plants of different Colombian regions. 
Furthermore, the combined effects of itracona-
zole and amphotericin B with the most actives 
samples, and their pharmacodynamics were 
evaluated in vitro by the chequerboard method 
and the time-kill curves, respectively.
Materials and methods 
Plant material 
Stems and leaves of 74 plants were collected 
in different regions of Colombia, from 2005 to 
2008, as part of a survey conducted by CENI-
VAM, a research center devoted to the study of 
aromatic plants and essential oils in Colombia. 
7KH WD[RQRPLF LGHQWLÀFDWLRQ RI WKH ERWDQLFDO
samples was performed by José Luis Fernandez 
at the Herbario Nacional de Colombia, Instituto 
de Ciencias Naturales, Facultad de Ciencias, Uni-
versidad Nacional de Colombia at Bogotá, whe-
re voucher specimens were deposited.
 
The selected plants belong to the following gene-
ra: Lippia (Verbenaceae) (26); Salvia (Lamiaceae) 
(7); Lepechinia (Lamiaceae) (3); Piper (Piperaceae) 
(3); Baccharis (Asteraceae) (2); Hedyosmum (Chlo-
ranthaceae) (3); Illicium (Schisandraceae) (2); 
Cymbopogon (Poaceae) (3); Minthostachiys mollis 
(Lamiaceae) (2); Thymus vulgaris (Lamiaceae) (2); 
and 5RVPDULQXVRIÀFLQDOLV(Lamiaceae) (2). Addi-
tionally, the following plants were also selected: 
Cananga odorata (Annonaceae), Tagetes lucida 
(Asteraceae), Eucalyptus citriodora (Myrtaceae), 
Turnera aff. diffusa Willd. ex Schult (Turneraceae), 
Nectandra tomentella (Lauraceae), Sigesbeckia 
agrestis (Asteraceae), Lantana fucata Lindl (Ver-
benaceae), Hyptis perbullata (Lamiaceae), Ori-
ganum vulgare (Lamiaceae) =LQJLEHU RIÀFLQDOH
(Zingiberaceae), Cascarilla saravena (Euphorbia-
ceae), Achyrocline alata (Kunth) DC (Asteraceae), 
Pimenta racemosa (Myrtaceae), Elettaria carda-
momum L (Zingiberaceae), Aloysia triphylla (Ver-
benaceae), Curcuma monteria (Zingiberaceae), 
Chenopodium ambrosioides L (Amaranthaceae), 
Bursera graveolens .XQWK7ULDQD	3ODQFKBur-
seraceae), and Morinda royoc L (Rubiaceae). 
Extracts and essential oils extraction 
Essential oils (59) and extracts (15) were evalua-
ted. The essential oils were extracted from dried 
stems and leaves (300 g) by microwave-assisted 
hydrodistillation as described (9). The extracts 
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were obtained from 40 g of dried leaves from 
each plant, macerated with 200 ml ethanol and 
left in suspension for 7 days at room temperatu-
UH&7KHPL[WXUHZDVÀOWHUHGDQGFRQFHQ-
trated using a Buchi rotavapor. Stock solutions of 
both oils and extracts, were prepared in DMSO 
YYIRUVXEVHTXHQWELRDVVD\V
Antifungal susceptibility testing
The Minimum Inhibitory Concentrations (MIC) of 
all samples were determined by the Antifungal 
Susceptibility Testing Subcommittee of the Eu-
ropean Committee on Antibiotic Susceptibility 
Testing (AFST-EUCAST) protocol (10). Candida al-
bicans ATCC 10231, C. albicans ATCC 90028 and 
a clinical blood isolate randomly selected from 
a group of clinical isolates of the Candida spe-
cies collected in our laboratory were used at 
inoculum size of 1-5 x 105 CFU/ml. The oils and 
H[WUDFWV ZHUH HYDOXDWHG DW ÀYH FRQFHQWUDWLRQV
RIǌJPO2LOVDQGH[WUDFWVZHUHFRQ-
sidered active when they exhibited MIC values 
HTXDO RU JUHDWHU WKDQ  ǌJPO ,WUDFRQD]ROH
(Sigma-Aldrich, Co., MO, USA) was used as a po-
VLWLYHFRQWURODWDUDQJHRIǌJPOZLWK
the strains C. krusei ATCC 6258 and C. parapsi-
losis ATCC 22019. A negative control (inoculum 
without treatment) was also included. MIC va-
lues were expressed as a geometric mean (GM-
MIC) of tests performed in duplicate in three di-
fferent assays against each Candida strain and 
the clinical isolate. 
Effect on germ tube formation and budding 
The effect on germ tube formation and budding 
was evaluated according to Ishida, et al. .(11). Di-
IIHUHQW FRQFHQWUDWLRQV  ǌJPO RI P. 
bredemeyeri Jacq, L. origanoides Kunth (B) oils 
and M. royoc L extract were tested with the three 
yeasts. A suspension of 1-5 x 105 CFU/ml in RPMI 
RI HDFK \HDVW ZDV SUHSDUHG DQG  ǌO ZHUH
added to the same volume of each sample con-
centration. Positive and negative controls with 
Q\VWDWLQDWǌJPO/D6DQWp%RJRWi&RORP-
bia) and cells without treatment, respectively, 
were included. 
For germ tube assays, after two hours of incu-
bation at 35 °C, the absence or presence of germ 
tubes was determined using a light microscopy 
(Nikon, Eclipse E200, Japan). Each sample was 
tested in duplicate using two different assays. To 
evaluate the effect on budding, after three hours 
of incubation at 35 °C, the budding cells/ml were 
counted using a hemacytometer. 
The statistical analysis of the effect on budding, 
was performed by R version 2.9.1 (The R Foun-
dation for Statistical Computing, ISBN 3-900051-
07-0) using ANOVA after transforming the 
response variable with square root. The Tukey 
multiple comparison test was used to compare 
strains with and without treatment. A 0.05 signi-
ÀFDQFHOHYHOZDVHPSOR\HG
Time-kill assay 
The in vitro pharmacodynamics of P. bredeme-
yeri Jacq oil and M. royoc L extract against C. 
albicans ATCC 90028 were performed by the 
method described by Klepser, et al.(12). An ini-
tial inoculum ranging from 1-5 x 105 CFU/ml 
was seeded on each sample, at concentrations 
of 0.25, 0.5, 1 and 2 times the MIC. The sam-
ples were incubated at 35 °C with agitation. At 
0, 4, 8, 12, and 24 hours, volumes of 10 μl were 
then spread onto potato dextrose agar (Oxoid, 
Basingstoke, Hampshire, UK) and incubated at 
37 °C for 24 hours to determine the number of 
CFU/ml. The limit of detection was 100 CFU/ml. 
Time-kill curves with itraconazole and amphote-
ricin B (Sigma-Adrich, Co, MO, USA) were used 
as fungistatic and fungicide controls, respecti-
vely. Experiments were carried out in duplicate 
in two separate experiments. Time-kill curves 
were constructed by plotting of mean ± stan-
dard deviation (SD) of colony count (log10 CFU/
ml) as a function of time (hours) with the Pris-
ma™ (GraphPad Software, Inc., USA, 2007) sta-
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WLVWLFDOSDFNDJH)XQJLFLGDODFWLYLW\ZDVGHÀQHG
DVORJ10 UHGXFWLRQLQ&)8PO from 
the starting inoculum (0.5 – 2.5 x 105 CFU/ml). 
Interaction of essential oils and drugs 
Assays were performed using the chequerboard 
method (13). Candida. albicans ATCC 10231 was 
XVHGDWDÀQDOFRQFHQWUDWLRQRI[5 CFU/
PO7KHÀQDOFRQFHQWUDWLRQVRIWKHLWUDFRQD]ROH
DQGDPSKRWHULFLQ%UDQJHGIURPǌJPOWR
ǌJPODQGWKHHVVHQWLDORLORIP. bredemeyeri 
-DFTIURPWRWRǌJPO7KHIUDFWLRQDO
inhibitory index (FICI) was calculated, and the in-
WHUSUHWDWLRQZDVGHWHUPLQHGDVIROORZVV\-
nergistic effect; >0.5 but <4 no interaction; and 
DQWDJRQLVWLFHIIHFW(13). 
Citotoxicity assay 
Cercopithecus aethiops African green monkey 
kidney cells (Vero cell line ATCC CCL-81) were 
used. The cells were grown in Eagle’s minimum 
essential medium (MEM) supplemented. The 
cytotoxicity of the essential oils and their com-
ponents was examined in vitro using an MTT 
(dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium 
bromide) (Sigma, New Jersey, USA) assay as des-
cribed by Betancur-Galvis, et al..(14). The minimal 
dilution of the essential oils that induced 50% 
growth inhibition of the cells was expressed as 
inhibitory concentration 50% (IC50). The IC50 va-
lues for each compound were obtained by linear 
regression analysis of the dose-response curves 
generated from the absorbance data with the R 
(Development Core Team, Vienna, Austria, 2008) 
statistical package. IC50 values were expressed as 
the mean ± standard deviation (M ± SD) of two 
independent experiments done in quadruplicate.
Results 
The MICs of 13 active samples (GM-MIC range 
157.5-500 μg/ml) tested against C. albicans and 
the respective IC50 values, are presented in Table 
1. The most active samples were the oils from P. 
bredemeyeri Jacq (GM-MIC of 157.5, 176.8 and 
222.7 μg/ml for C. albicans ATCC 10231, C. al-
bicans ATCC 90028 and the clinical isolate, res-
pectively) and L. origanoides Kunth (B) (GM-MIC 
RIǌJPOIRUC. albicans ATCC 
10231, C. albicans ATCC 90028, and the clinical 
isolate, respectively). Also M. royoc L extract was 
DFWLYH *00,&    ǌJPO ZLWK WKH WKUHH
evaluated yeasts (Table 1).The MIC values of the 
positive control itraconazole with C. parapsilosis 
ATCC 22019 and C. krusei ATCC 6258 (0.169 and 
0.999, respectively), were in the acceptable ran-
ge according to the standard protocol (0.3125-
DQGǌJPOUHVSHFWLYHO\
 
Piper bredemeyeri Jacq and L. origanoides Kunth 
(B) oils inhibited the formation of germ tubes 
in the two strains and in the clinical isolate at a 
 JPO FRQFHQWUDWLRQ $OVR M. royoc L 
extract inhibited the formation of germ tube in 
both: C. albicans ATCC 90028 strain and in the cli-
nical isolate, at the same concentrations. The in-
hibition in C. albicans$7&&ZDVDWD
μg/ml concentration. Germ tubes were observed 
in the negative control, but not in the positive 
control. In addition, the treatment of the strains 
and the clinical isolate with P. bredemeyeri Jacq 
and L. origanoides Kunth (B) oils, and M. royoc 
extract, inhibited the process of budding, at 250 
μg/ml. The decrease of budding in treated blas-
toconidia, compared with the negative control 
ZDVVLJQLÀFDQWO\GLIIHUHQW S7KHSRVLWLYH
control inhibited the budding, and in the negative 
control there was a normal rate of budding.
The killing activity of P. bredemeyeri Jacq oil and M. 
royoc L extract against C. albicans ATCC 90028 as 
well as itraconazole and amphotericin B is repre-
sented in Figure 1. At 2 times the MIC, P. bredeme-
yeri Jacq oil, after 4 hours of incubation, showed 
fungicidal activity similar to amphotericin B (Figu-
re 1a and Figure 1c, respectively). It was found that 
at 0.5 times and 1 time the MIC concentration the-
re was a reduction in growth until approximately 
8 hours, when colony counts continued to grow 
near the initial starting inoculum. M. royoc L ex-
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tract showed fungicidal activity at 2 times the MIC 
after 8 hours of incubation (Figure 1b). At lower 
concentrations (0.25, 0.5 and 1 times the MIC), we 
GLGQRWÀQGVLJQLÀFDQWUHGXFWLRQLQ&)8PO (<3 - 
log10) compared with the starting inoculum. 
A synergistic effect was obtained for the combi-
nation of itraconazole and P. bredemeyeri Jacq 
(FICI range 0.09-0.13), but no interaction was 
detected for the combination of P. bredemeyeri 
Jacq and amphotericin B (FICI=1.06). 
According to the American National Cancer Ins-
titute (USA) criteria samples with anti-C. albicans 
activity were not cytotoxic on Vero cells excluding 
P. bredemeyeri Jacq oil (IC50=15.2 ± 3) (Table 1). 
Discussion
Plants, marine organisms, and microbes usua-
lly produce biologically active compounds as a 
defense against predators and competition with 
neighbors. Thus, it seems logical that most of 
the drugs derived from natural sources have an-
ticancer or anti-infective properties. Important 
antifungal agents such as polyenes, echinocan-
dins/pneumocandins, aureobasidins and sorda-
rins had their origin in natural products (15). 
In this study, oils and extracts from medicinal 
and aromatic plants were tested against two C. 
albicans strains and a clinical isolate. Currently, 
there is no agreement on the acceptable level 
of activity for natural products when they are 
compared to standard drugs. Aligiannis, et al.(16), 
VXJJHVWHG D FODVVLÀFDWLRQRI DQWLIXQJDO DFWLYLW\
in plant derivates (antifungal activity based on 
MIC results) as follows: strong inhibitors, MIC up 
to 0.5 mg/ml; moderate inhibitors, MIC between 
0.6 and 1.5 mg/ml; weak inhibitors, MIC above 
1.6 mg/ml. According to these criteria, we found 
strong anti-C. albicans activity in 17.57% of the 
evaluated samples (Table 1). 
Previous studies have shown the antifungal ac-
tivity in extracts and oils of plants belonging to 
Piper, Morinda, and Lippia genus (17-19). López, et 
al.(19), determined a MIC value of 100.000 μg/
ml against C. albicans of the methanolic extract 
from the plant Piper lanceafolum, using an agar 
diffusion method. In contrast, in this study, the 
microdilution standard method AFST-EUCAST 
was used, and lower MICs with P. bredemeyeri 
Jacq were found (GM-MIC of 157.5, 176.8, and 
222.7 μg/ml, with the three evaluated yeasts) 
(Table 1). 
Figure 1. Time-kill plots against C. albicans ATCC 90028 of a) P. bredemeyeri Jacq oil, b) 
M. royoc L y P. bredemeyeri -DFTH[WUDFWFDPSKRWHULFLQH%DQGGLWUDFRQD]ROHŃ*URZWK
control;  0.25x MIC; c 0.5x MIC; d[0,&©;0,& 4x MIC  
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This is one of the few studies focused on evalua-
ting the anti-C. albicans activity of L. origanoides 
oils using a standard method for determination 
of MIC by broth dilution of fermentative yeast. 
Oliveira, et al .(20), also found important activi-
ty against C. albicans in an oil of L. origanoides 
using an agar diffusion method; however, we 
cannot compare our results with theirs, because 
they used a technique that determined inhibi-
tion zone (mm) but not MIC (μg/ml).
Candida albicans is a dimorphic fungus, able to 
JURZDV\HDVWRUÀODPHQWRXVIRUP7KH\HDVWWR
hyphal transition begins with the formation of 
a germ tube and it is the initial stage of hyphal 
formation (21). The oils from P. bredemeyeri Jacq 
and L. origanoides Kunth (B) and the M. royoc L 
extract inhibited the germ tube formation. It is 
possible that those oils and extracts are acting 
on an important process in the morpho-trans-
formation of C. albicans, as wall or membrane 
integrity or reorganization of the cytoskeleton (22, 
23). This characteristic could make a new antifun-
gal more selective towards the infecting germ 
than towards the host cells. 
The concentration at which P. bredemeyeri Jacq 
and L. origanoides Kunth (B) oils were able to 
inhibit the germ tube formation of C. albicans 
 JPO RU  JPO DUH ZLWKLQ WKH
concentration ranges published for this activity 
with Melaleuca alternifolia oil (tea tree oil) (0.25 
and 12.5% (v/v, approximately 2.25 and 112.5 
μg/ml, respectively) (24). Those results make our 
ÀQGLQJVSURPLVLQJ LIZHFRQVLGHU WKDW WHD WUHH 
oil is used as commercial product for treatments 
of fungal infections as oropharingeal and vagi-
nal infections by C. albicans (24-26).
Candida albicans has isotropic growth by budding 
and several antifungal drugs and plant extracts can 
inhibit budding of yeast cells (21, 27). In this study the 
treatment of the strains and the clinical isolate with 
P. bredemeyeri Jacq and L. origanoides Kunth (B) 
oils, and M. royoc extract, decreased blastoconidia 
budding at 250 μg/ml compared with the negative 
control (p<0.05). Previous studies have suggested 
that the deleterious effect of the essential oil on the 
cell wall of the fungus could be the main reason for 
the decrease in the rate of yeast budding, because 
the cell wall is necessary for cell division (27). 
Table 1. Geometric means of minimal inhib itory concentration (GM – MIC, μg/mll) and inhibitory concentration 50% (IC50) of essential oils and 
extracts actives against Candida albicans 
GM - MIC (μg/ml) IC50 (M ± SD) R2
Plant
Voucher 
specimen
Sample
C. albicans 
ATCC 10231
C. albicans 
ATCC 90028
C. albicans 
(Clinical isolate)
Vero ATCC CCL-81
Lippia alba 007 484650 Oil * 353.6 420.4 32.8 ± 3.6 0.89
Lippia origanoides 512271 Oil 396.9 500 500 52.3 ± 11.5 0.8
Lippia origanoides 512075 Oil 250 250 315 74.6 ± 16.9 0.75
Lippia origanoides 512075 Oil 500 500 500 60.4± 11.2 0.83
Piper bredemeyeri Jacq. 516939 Oil 157.5 176.8 222.7 15.2 ± 3 0.81
Turnera aff. diffusa Willd. ex 
Schult.
516293 Oil * 353.6 500 52.2 ± 5.2 0.93
Lippia origanoides Kunth (A) 517741 Oil 500 500 500 31.4 ± 5.6 0.75
Lippia origanoides Kunth (B) 517741 Oil 157.5 157.5 198.4 31.4 ± 5.6 0.75
Lippia origanoides Kunth (C) 517741 Oil 500 396.9 396.9 34.4 ± 5.9 0.76
Morinda royoc L. 512222 Extract 250 250 250  NA
Piper hispidum Sw. 519969 Oil 250 280.6 250 51.7 ± 9.3 0.8
Lippia origanoides 512087 Oil 500 500 500 104.4 ± 5.9 0.98
Cymbopogon citratus 531013 Oil * 500 500  NA
* MIC>500 μg/ml; R2OLQHDUUHJUHVVLRQFRHIÀFLHQW1$QRWDSSOLFDEOH
 $62&,$&,Ï1&2/20%,$1$'(,1)(&72/2*Ë$ ,QIHFWLR
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The time-kill studies are useful for the evaluation 
of the pharmacodynamics’ characteristics of new 
antimicrobial agents (28). The oil of P. bredemeyeri 
Jacq and the extract of M. royoc L showed a fun-
gicidal activity on C. albicans at 2 x MIC after 4 
and 8 hours, respectively. It is clinically more im-
SRUWDQWWRÀQGIXQJLFLGDOFRPSRXQGVWKDQIXQ-
gistatic, particularly in HIV patients, because the 
prophylactic use of fungistatic drugs has been 
associated with an increased frequency of innate 
or acquired drug resistance in clinical isolates (29). 
Chemical analyses of most active essential oils 
against C. albicans have been carried out in our 
laboratory. The main compounds of P. bredeme-
yeri Jacq oil were terpenes alpha-pinene (20.3%) 
and beta-pinene (32.3%) (unpublished data). 
Other studies have demonstrated that those ter-
penes act on cellular integrity, inhibition of the 
respiration and ion transport processes, and in-
crease membrane permeability in C. albicans (30, 
31). Hence, it is possible that the antifungal acti-
vity of P. bredemeyeri Jacq oil could be explained 
by a higher concentration of those monoterpe-
ne hydrocarbons. On the other hand, chemical 
analyses of oil from L. origanoides Kunth (B) have 
also been carried out in our laboratory. The main 
components were the oxygenated monoterpenes 
thymol (43.8%) and carvacrol (17.3%). The antimi-
crobial activities of those terpenes have also been 
demonstrated, and their mechanism of action has 
been associated with membrane permeability (20). 
7R WKH EHVW RI RXU NQRZOHGJH WKLV LV WKH ÀUVW
time that antifungal activity of M. royoc L extract 
is described. Morinda genus contains substan-
tial amounts of anthraquinones, especially in the 
roots. The antifungal activity of those quinones 
has been demonstrated (32), so it is possible that 
anti-C. albicans activity of M. royoc L extract may 
be produced by the presence of such molecules. 
In our laboratory, the antifungal activity of L. 
origanoides Kunth (B) and M. royoc L extract 
against Aspergillus fumigatus,$ÁDYXV&NUXVHL
and C. parapsilosis has been demonstrated. Un-
like P. bredemeyeri Jacq oil only showed activity 
against C. krusei (unpublished data). 
Potential synergy of essential oils with antibiotics 
has been previously considered with the aims of 
increasing the rate of fungal killing, shortening 
the duration of therapy, avoiding the emergence 
of drug resistance, expanding the spectrum of 
activity, and decreasing drug-related toxicity by 
allowing lower doses of antifungal agents to be 
administered (33). In this study, a synergistic effect 
was obtained when itraconazole and the oil from 
P. bredemeyeri Jacq were combined (FICI range, 
0.09-0.13). No interaction was detected with the 
combination of the oil of P. bredemeyeri Jacq and 
amphotericin B (FICI=1.06).
The criteria of cytotoxic activity for the crude ex-
tracts as established by the American National 
Cancer Institute (USA), is an IC50 of less than 30 μg/ml (34). According to these criteria, we consi-
der that oils with anti-C. albicans activity and M. 
royoc L extract were not cytotoxic on Vero cells 
(IC50JPOH[FOXGLQJWKHRLORIP. bredeme-
yeri Jacq (IC50
=15.2 ± 3 μg/ml) (Table 1). Gonzá-
lez, et al..(35), orally administered an extract of M. 
royocLQUDWVDQGWKH\GLGQRWÀQGWR[LFHIIHFWV
Both our results of in vitro citotoxicity, as well as 
the toxicity in vivo demonstrated by González, et 
al..(35), suggest that M. royoc L extract may be a 
candidate for developing an antifungal of natu-
ral origin against C. albicans.
The discovery of a novel natural product for 
therapeutic use is a slow process. For example, 
Taxol, an anticancer agent developed from the 
plant Taxus brevifolia, was discovered after a 
random screening of 35,000 plant samples that 
took more than 25 years (36, 37). 
In conclusion, the results of this study suggest that 
Colombian medicinal and aromatic plants repre-
sent an untapped source of compounds with anti-
C. albicans activity that could be a resource in the 
development of therapeutically natural products.
,QIHFWLR
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